001     140088
005     20240321220736.0
024 7 _ |a 10.1111/jgs.15358
|2 doi
024 7 _ |a pmid:29566430
|2 pmid
024 7 _ |a 0002-8614
|2 ISSN
024 7 _ |a 1532-5415
|2 ISSN
024 7 _ |a altmetric:34956344
|2 altmetric
037 _ _ |a DZNE-2020-06410
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Taipale, Heidi
|b 0
245 _ _ |a Use of Antiepileptic Drugs and Dementia Risk-an Analysis of Finnish Health Register and German Health Insurance Data.
260 _ _ |a Oxford [u.a.]
|c 2018
|b Wiley-Blackwell
264 _ 1 |3 online
|2 Crossref
|b Wiley
|c 2018-03-22
264 _ 1 |3 print
|2 Crossref
|b Wiley
|c 2018-07-01
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1591373055_14981
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a To evaluate the association between regular antiepileptic drug (AED) use and incident dementia.Case-control analysis.Finnish public health register and German health insurance data.Individuals with dementia of any type (German data, N=20,325) and Alzheimer's disease (AD; Finnish data, N=70,718) were matched with up to four control persons without dementia.We analyzed the association between regular AED use and dementia. To address potential protopathic bias, a lag time of 2 years between AED use and dementia diagnosis was introduced. Odds ratios (ORs) were calculated by applying conditional logistic regression, adjusted for potential confounding factors such as comorbidities and polypharmacy.Regular AED use was more frequent in individuals with dementia than controls. Regular use of AEDs was associated with a significantly greater risk of incident dementia (adjusted OR=1.28, 95% confidence interval (CI)=1.14-1.44) and AD (adjusted OR=1.15, 95% CI=1.09-1.22) than no AED use. We also detected a trend toward greater risk of dementia with higher exposure. When AEDs with and without known cognitive adverse effects (CAEs) were compared, a significantly greater risk of dementia was observed for substances with known CAEs (dementia: OR=1.59, 95% CI=1.36-1.86; AD: OR=1.19, 95% CI=1.11-1.27).AEDs, especially those with known CAEs, may contribute to incident dementia and AD in older persons.
536 _ _ |a 344 - Clinical and Health Care Research (POF3-344)
|0 G:(DE-HGF)POF3-344
|c POF3-344
|f POF III
|x 0
536 _ _ |a 345 - Population Studies and Genetics (POF3-345)
|0 G:(DE-HGF)POF3-345
|c POF3-345
|f POF III
|x 1
542 _ _ |i 2018-03-22
|2 Crossref
|u http://doi.wiley.com/10.1002/tdm_license_1.1
542 _ _ |i 2018-03-22
|2 Crossref
|u http://onlinelibrary.wiley.com/termsAndConditions#vor
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a Anticonvulsants
|2 NLM Chemicals
650 _ 2 |a Aged
|2 MeSH
650 _ 2 |a Aged, 80 and over
|2 MeSH
650 _ 2 |a Anticonvulsants: adverse effects
|2 MeSH
650 _ 2 |a Anticonvulsants: therapeutic use
|2 MeSH
650 _ 2 |a Case-Control Studies
|2 MeSH
650 _ 2 |a Cognition
|2 MeSH
650 _ 2 |a Comorbidity
|2 MeSH
650 _ 2 |a Correlation of Data
|2 MeSH
650 _ 2 |a Dementia: diagnosis
|2 MeSH
650 _ 2 |a Dementia: epidemiology
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Finland: epidemiology
|2 MeSH
650 _ 2 |a Geriatric Assessment: methods
|2 MeSH
650 _ 2 |a Germany: epidemiology
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Insurance Claim Review: statistics & numerical data
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Registries: statistics & numerical data
|2 MeSH
650 _ 2 |a Risk Factors
|2 MeSH
700 1 _ |a Gomm, Willy
|0 P:(DE-2719)2811376
|b 1
|u dzne
700 1 _ |a Broich, Karl
|b 2
700 1 _ |a Maier, Wolfgang
|0 P:(DE-2719)2000015
|b 3
|u dzne
700 1 _ |a Tolppanen, Anna-Maija
|b 4
700 1 _ |a Tanskanen, Antti
|b 5
700 1 _ |a Tiihonen, Jari
|b 6
700 1 _ |a Hartikainen, Sirpa
|b 7
700 1 _ |a Haenisch, Britta
|0 P:(DE-2719)2810511
|b 8
|e Last author
|u dzne
773 1 8 |a 10.1111/jgs.15358
|b : Wiley, 2018-03-22
|n 6
|p 1123-1129
|3 journal-article
|2 Crossref
|t Journal of the American Geriatrics Society
|v 66
|y 2018
|x 0002-8614
773 _ _ |a 10.1111/jgs.15358
|g Vol. 66, no. 6, p. 1123 - 1129
|0 PERI:(DE-600)2040494-3
|n 6
|q 66:6<1123 - 1129
|p 1123-1129
|t Journal of the American Geriatrics Society
|v 66
|y 2018
|x 0002-8614
909 C O |o oai:pub.dzne.de:140088
|p VDB
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)2811376
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-2719)2000015
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 8
|6 P:(DE-2719)2810511
913 1 _ |a DE-HGF
|b Forschungsbereich Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-344
|2 G:(DE-HGF)POF3-300
|v Clinical and Health Care Research
|x 0
913 1 _ |a DE-HGF
|b Forschungsbereich Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-345
|2 G:(DE-HGF)POF3-300
|v Population Studies and Genetics
|x 1
914 1 _ |y 2018
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J AM GERIATR SOC : 2021
|d 2022-11-15
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-15
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-15
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2022-11-15
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2022-11-15
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-15
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-15
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-15
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2022-11-15
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0130
|2 StatID
|b Social Sciences Citation Index
|d 2022-11-15
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b J AM GERIATR SOC : 2021
|d 2022-11-15
920 1 _ |0 I:(DE-2719)1013010
|k AG Hänisch
|l Pharmacoepidemiology in Neurodegenerative Disorders
|x 0
920 1 _ |0 I:(DE-2719)7000001
|k U Clinical Researchers - Bonn
|l U Clinical Researchers - Bonn
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1013010
980 _ _ |a I:(DE-2719)7000001
980 _ _ |a UNRESTRICTED
999 C 5 |a 10.3988/jcn.2008.4.3.99
|9 -- missing cx lookup --
|2 Crossref
|o 10.3988/jcn.2008.4.3.99
999 C 5 |a 10.1177/1756285611417920
|9 -- missing cx lookup --
|2 Crossref
|o 10.1177/1756285611417920
999 C 5 |a 10.1111/j.1535-7511.2005.00056.x
|9 -- missing cx lookup --
|2 Crossref
|o 10.1111/j.1535-7511.2005.00056.x
999 C 5 |a 10.1017/S1041610205002024
|9 -- missing cx lookup --
|2 Crossref
|o 10.1017/S1041610205002024
999 C 5 |a 10.1016/j.jns.2006.11.004
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.jns.2006.11.004
999 C 5 |a 10.1017/S1041610207006540
|9 -- missing cx lookup --
|2 Crossref
|o 10.1017/S1041610207006540
999 C 5 |a 10.1007/s11940-012-0166-9
|9 -- missing cx lookup --
|2 Crossref
|o 10.1007/s11940-012-0166-9
999 C 5 |a 10.2174/1570159X14666151208114232
|9 -- missing cx lookup --
|2 Crossref
|o 10.2174/1570159X14666151208114232
999 C 5 |a 10.1111/jgs.12730
|9 -- missing cx lookup --
|2 Crossref
|o 10.1111/jgs.12730
999 C 5 |a 10.1017/S1041610213000768
|9 -- missing cx lookup --
|2 Crossref
|o 10.1017/S1041610213000768
999 C 5 |a 10.1136/bmjopen-2016-012100
|9 -- missing cx lookup --
|2 Crossref
|o 10.1136/bmjopen-2016-012100
999 C 5 |a 10.1186/s13195-015-0146-x
|9 -- missing cx lookup --
|2 Crossref
|o 10.1186/s13195-015-0146-x
999 C 5 |a 10.3233/JAD-151006
|9 -- missing cx lookup --
|2 Crossref
|o 10.3233/JAD-151006
999 C 5 |a 10.1016/B978-0-444-52891-9.00073-7
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/B978-0-444-52891-9.00073-7
999 C 5 |a 10.1186/s12911-015-0140-z
|9 -- missing cx lookup --
|2 Crossref
|o 10.1186/s12911-015-0140-z
999 C 5 |y 2009
|2 Crossref
|o Qiu 2009
999 C 5 |a 10.1136/bmjopen-2015-008853
|9 -- missing cx lookup --
|2 Crossref
|o 10.1136/bmjopen-2015-008853
999 C 5 |a 10.1111/ane.12700
|9 -- missing cx lookup --
|2 Crossref
|o 10.1111/ane.12700
999 C 5 |a 10.1007/s40263-015-0230-6
|9 -- missing cx lookup --
|2 Crossref
|o 10.1007/s40263-015-0230-6
999 C 5 |a 10.3233/JAD-150630
|9 -- missing cx lookup --
|2 Crossref
|o 10.3233/JAD-150630
999 C 5 |a 10.14581/jer.14010
|9 -- missing cx lookup --
|2 Crossref
|o 10.14581/jer.14010
999 C 5 |a 10.3390/ph3061909
|9 -- missing cx lookup --
|2 Crossref
|o 10.3390/ph3061909
999 C 5 |a 10.1038/nm.3639
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/nm.3639
999 C 5 |a 10.1007/s40263-015-0305-4
|9 -- missing cx lookup --
|2 Crossref
|o 10.1007/s40263-015-0305-4


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21